A 57-year-old man visited our hospital with right hypochondralgia. Abdominal contrast CT showed a 10 cm sized mass in S6-7of the liver and abdominal hemorrhage areas. The tumor showed extrahepatic growth. Blood a-fetoprotein(AFP)was high at 4,447.9ng/mL. Hemostasis was performed through emergency transcatheter arterial embolization. At a later date, upper gastrointestinal endoscopy showed a 20 mm sized type 2 lesion in the gastric corpus. Therefore, we performed distal gastrectomy and right hepatic lobectomy. In histopathological findings, the gastric lesion showed identified as a hepatoid adenocarcinoma, which was positive for AFP protein. The liver lesion was negative for AFP protein, but was similar to hepatoid adenocarcinoma, and no fibrosis was observed in the background liver. Therefore, we diagnosed the tumor as a liver metastasis of AFP-producing gastric cancer. On postoperative day 31, CT showed a metastatic lesion in the S1 of the liver and ascites. Chemotherapy was not successful, and the patient died on postoperative day 75. The resection rate of metastatic liver tumor in AFP-producing gastric cancer is low. This is the second case in Japan, wherein a surgery was performed for a ruptured liver metastatic lesion.

Download full-text PDF

Source

Publication Analysis

Top Keywords

afp-producing gastric
12
gastric cancer
12
liver
8
liver metastatic
8
hepatoid adenocarcinoma
8
afp protein
8
postoperative day
8
metastatic lesion
8
gastric
5
lesion
5

Similar Publications

α-Fetoprotein (AFP)-producing gastric carcinoma (AFPGC) is a rare subtype of gastric cancer (GC) with controversial classification methods. Hepatoid adenocarcinoma of the stomach (HAS) is another rare subtype of GC. Its definition intersects with that of AFPGC, but it is much rarer.

View Article and Find Full Text PDF

Inflammation-related markers and prognosis of alpha-fetoprotein producing gastric cancer.

World J Gastrointest Oncol

September 2024

Department of Oncology, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, Jiangsu Province, China.

Article Synopsis
  • The study investigates the role of inflammation-related blood markers (like NLR, PLR, MLR, SII, SIRI, and PNI) in predicting outcomes for patients with alpha-fetoprotein (AFP) producing gastric cancer (GC) and compares them to non-AFP producing GC patients.
  • Findings show that AFP+ patients exhibit higher inflammatory marker levels and poorer overall survival compared to AFP- patients, indicating that these markers can indeed predict prognosis and mortality risk within one year.
  • It concludes that AFP producing gastric cancer should be treated as a distinct category due to its unique immune microenvironment and clinical characteristics, emphasizing the need for tailored approaches in treatment.
View Article and Find Full Text PDF

Alpha-fetoprotein (AFP) elevation is a well-known biomarker in various diseases, particularly in the diagnosis of hepatocellular carcinoma (HCC). Intracellular AFP has been previously implicated in promoting tumorigenesis. In this study, we discovered that AFP enhances the stability of oncoproteins c-MYC and c-MET, thereby facilitating the progression of liver and gastric tumors.

View Article and Find Full Text PDF

An unusual cause of significantly elevated blood alpha-fetoprotein levels: a case report and literature review.

Front Oncol

May 2024

Department of General Medicine, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou Central Hospital, The Affiliated Central Hospital of Huzhou University, Huzhou, Zhejiang, China.

Alpha-fetoprotein (AFP) serves as a crucial diagnostic marker for primary hepatocellular carcinoma (HCC) and germ cell tumors (GCTs), with rare instances of significantly elevated levels in other diseases. In this study, we present a case of an elderly patient who was diagnosed with AFP-producing gastric cancer (AFPGC) following an elevated AFP result during physical examination. In investigating liver cancer at an early stage, the diagnosis was missed because of failure in detecting the lesion, resulting in delayed treatment initiation.

View Article and Find Full Text PDF

A 25-year-old male received palliative total gastrectomy plus D1 dissection plus Roux-en-Y reconstruction for hemorrhagic gastric cancer with left Virchow lymph node metastasis in 2013. The final diagnosis was Type 2, pT4a(se), pap>tub2 >hepatoid adenocarcinoma, pN3b, sM1, fStage Ⅳ. Because AFP was as high as 11,000 ng/mL, he was diagnosed with AFP-producing gastric cancer and started S-1 plus CDDP therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!